Project Grant R21AI188683
Award Date 8/18/25
Completion Date 7/31/27
Dollars Obligated $241K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research to define the mechanistic drivers of impaired B cell response to influenza A virus vaccine under conditions of obesity. The total funding amount is $148,880, awarded on November 1, 2025, with an ultimate completion date of June 30, 2027. The research will be conducted by St. Jude Children's Research Hospital Inc. to uncover defects...
- The federal Project Grant award of $441,375 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at Childrens Hospital Medical Center in Cincinnati, Ohio to investigate the cell-specific roles of CD153 and CD30 in regulating immune responses, with a focus on understanding age-related declines in immune function. The research aims to provide insights that could help reinvigorate immune responses in aging...
- This $2,190,435 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to understand the impact of obesity on humoral B cell immunity. The research aims to investigate how obesity-driven expansion of inflammatory TBET+CD11C+ B cells inhibits protective germinal center responses and impairs vaccine efficacy in obese individuals. Key activities include in vitro and in vivo assays, RNA sequencing,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $851,294 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Texas Health Science Center at San Antonio. The grant funding supports research to dissect the mechanisms behind altered immune responses during obesity. Key objectives include understanding how obesity induces expansion of inflammatory TBet+ B cells and how this skews humoral immunity, rendering obese...
- This federal Project Grant award, valued at $3,147,392.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research at the Childrens Hospital Medical Center in Cincinnati, Ohio to investigate how dendritic cells and the unfolded protein response (UPR) play a role in generating pathogen-specific Th17 immune responses. The research aims to advance the understanding of...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $704,041 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Regents of the University of California at Riverside. The grant supports research to investigate sex-dependent innate immune mechanisms that regulate type 2 immunity and obesity. The research aims to study macrophage-eosinophil interactions and the role of the RELMA protein in protecting against diet-induced obesity and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $107,010 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to Washington University in St. Louis. The grant, awarded on January 2, 2025, will support research on how diet-induced obesity impacts immune response and resistance to norovirus, a leading cause of viral gastroenteritis worldwide. Preliminary data indicates that mice on a high-fat diet were able to clear...
- The University of Colorado-Denver received a $730,392 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), funded under the Allergy and Infectious Diseases Research program (CFDA 93.855). This 5-year grant, with a period of performance from June 17, 2025 to May 31, 2030, supports research to investigate the role of adipose tissue and eosinophils in regulating airway function and inflammation, particularly in the context of obesity and asthma. The research...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $501,800 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Children's Hospital Corporation (doing business as Boston Children's Hospital). The award, with a period of performance from Aug 4, 2025 to Jul 31, 2027, will fund research to use cryo-electron tomography to gain new molecular insights into the divergent cell division process of the Plasmodium parasite, which causes...
- This $441,375 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research on the transcriptional mechanisms underlying chronic inflammation in genetically diverse liver macrophages (Kupffer cells) during metabolic dysfunction-associated steatotic liver disease (MASLD). The research aims to understand how genetic variation in regulatory regions controls gene expression in Kupffer cells, which play a...